{"entity":{"id":"ranata-therapeutics","kind":"company","name":"Ranata Therapeutics","aka":["Ranata Tx"],"tldr":"Ranata Therapeutics builds antibodies and bispecific antibodies against the unique features of an individual patient's cancer cells.","summary":"Ranata Therapeutics harnesses the uniqueness of a patient's cancer cells to build biologic therapies, antibodies or bispecifics, against that cancer: personalised medicine inspired by the individual's biology. It is an Even One Ventures portfolio company with no published candidates.","asOf":"2026-09-10","links":[{"label":"Official website","url":"https://ranatatx.com/"},{"label":"Even One Ventures portfolio","url":"https://evenone.ventures/"}],"tags":["startup","evenone-portfolio","oncology"],"related":[],"cancers":[],"sections":[],"technologies":["bispecific-antibody"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"hq":"United States (head office not published)","country":"US","companyType":"biotech","website":"https://ranatatx.com/","stage":"startup","investors":["evenone-ventures"],"funding":[]},"route":"/companies/ranata-therapeutics/","neighbours":{"technology":[{"id":"bispecific-antibody","kind":"technology","name":"Bispecific antibodies","route":"/technologies/bispecific-antibody/"}],"company":[{"id":"evenone-ventures","kind":"company","name":"Even One Ventures","route":"/companies/evenone-ventures/"}]}}